Extended release of highly water soluble isoniazid attained through cocrystallization with curcumin
The aim of this study was to design and evaluate a cocrystal capable of releasing a highly
water soluble drug, isoniazid (INH), over a period of longer than several hours by forming a …
water soluble drug, isoniazid (INH), over a period of longer than several hours by forming a …
Energy-efficient and environment-friendly method to prepare monodispersed silica stationary phases for simultaneous separation of compound drugs
Z Huo, QH Wan, L Chen - Journal of Chromatography A, 2020 - Elsevier
An energy-efficient and environment-friendly approach to prepare porous monodispersed
micro-sized silica particles with methyltrimethoxysilane (MTMS) as the precursor is …
micro-sized silica particles with methyltrimethoxysilane (MTMS) as the precursor is …
Epoxide‐derived mixed‐mode chromatographic stationary phases for separation of active substances in fixed‐dose combination drugs
S Zhang, QH Wan, Y Li - Journal of separation science, 2019 - Wiley Online Library
A method for the preparation of novel mixed‐mode reversed‐phase/strong cation exchange
stationary phase for the separation of fixed‐dose combination drugs has been developed …
stationary phase for the separation of fixed‐dose combination drugs has been developed …
[HTML][HTML] Лекарственная совместимость в лечении хронических инфекционных болезней
ЕС Базрова, ГД Каминский, ЛЮ Ильченко… - Архивъ внутренней …, 2021 - cyberleninka.ru
В статье рассматриваются вопросы особенностей фармакотерапии у коморбидных
пациентов с хроническими инфекционными заболеваниями и сопутствующей …
пациентов с хроническими инфекционными заболеваниями и сопутствующей …
Effect of Fixed‐Dose Combinations Antituberculosis and Separate Formulations on Clinical Symptoms, Weight Gain, Adverse Effect and Plasma Concentration in …
T Sundari, N Mariana… - Medica …, 2023 - medicahospitalia.rskariadi.co.id
BACKGROUND: Fixed Dose Combination (FDC) was aimed to simplify TB therapy and
facilitate physician and patient compliance. OBJECTIVE: We aimed to evaluate the effect of …
facilitate physician and patient compliance. OBJECTIVE: We aimed to evaluate the effect of …
Drug Compatibility in Treatment of Chronic Infectious Diseases
ES Bazrova, GD Kaminskiy, LY Ilchenko… - The Russian Archives …, 2021 - medarhive.ru
The article considers the features of pharmacotherapy of patients with chronic infectious
diseases and co-morbidities in conditions of polypharmacy, the principles of drug …
diseases and co-morbidities in conditions of polypharmacy, the principles of drug …
The four-drug fixed-dose combination reduced the loss to follow up from TB treatment in Brazil: additional evidence comparing two prospective cohorts at the same …
M de Aguiar Oliveira, J de Lima Bento, RR Costa… - 2022 - researchsquare.com
Background: Loss to follow up (LTFU) is an obstacle to improving tuberculosis (TB)
indicators. The aim of this study was to evaluate the incidence of and risk factors for LTFU …
indicators. The aim of this study was to evaluate the incidence of and risk factors for LTFU …
Razvoj analitičkih metoda za karakterizaciju nove višekomponentne formulacije u liječenju tuberkuloze
V Petruševska - 2020 - dr.nsk.hr
Sažetak Terapija tuberkuloze provodi se primjenom više lijekova istovremeno. Iz tog razloga
razvijeni su ljekoviti oblici koji sadrže više aktivnih tvari (engl. Fixed Dose Combination …
razvijeni su ljekoviti oblici koji sadrže više aktivnih tvari (engl. Fixed Dose Combination …